Table 2.
Group | Time | FBG (mmol/L) |
---|---|---|
CON | Before treatment | 4.33±0.142 |
After treatment | 4.42±0.255 | |
DCM | Before treatment | 16.11±0.599## |
After treatment | 16.20±0.799## | |
Met | Before treatment | 16.09±0.396 |
After treatment | 9.56±0.257▲▲ | |
ZGJTSXFL | Before treatment | 16.09±0.629 |
After treatment | 12.95±0.761▲▲ | |
ZGJTSXFM | Before treatment | 16.16±0.199 |
After treatment | 9.58±0.292▲▲**ΔΔ | |
ZGJTSXFH | Before treatment | 15.77±0.566 |
After treatment | 13.02±0.258▲▲ |
Notes: ##P<0.01, compared with the CON group; ▲▲P<0.01, compared with the DCM group; **P<0.01, compared with the ZGJTSXFL group; ΔΔP<0.01, compared with the ZGJTSXFH group.